%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Jennie McKenney, Anders Chen, Karen W. Hoover, Jane Kelly, David Dowdy, Parastu Sharifi, Patrick S. Sullivan, Eli S. Rosenberg
Optimal costs of HIV pre-exposure prophylaxis for men who have sex with men
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 9 0 R/Annots 10 0 R/Contents 11 0 R/TrimBox[0 0 612 792]>>
endobj
10 0 obj
[12 0 R 13 0 R 14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R]
endobj
12 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref001)>>
endobj
13 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref002)>>
endobj
14 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref003)>>
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref004)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref003)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref005)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref006)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref007)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref008)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref010)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref009)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref011)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref012)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref016)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref017)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref019)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref020)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref021)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref017)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref019)>>
endobj
32 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref022)>>
endobj
33 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref024)>>
endobj
34 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref012)>>
endobj
35 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref016)>>
endobj
36 0 obj
<>/Border[0 0 0]/Dest(Rpone.0178170.ref012)>>
endobj
37 0 obj
<>/Border[0 0 0]/A 38 0 R>>
endobj
38 0 obj
<>
endobj
11 0 obj
[39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R 61 0 R]
endobj
39 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 666.2299 m
199.9998 666.2299 l
199.9998 666.7299 l
575.9997 666.7299 l
f*
0.83 0.64 0.02 0 k
308.6362 565.0583 m
313.3984 565.0583 l
h
f*
317.8205 565.0583 m
322.5827 565.0583 l
h
f*
381.9402 552.0189 m
386.7024 552.0189 l
h
f*
391.1244 552.0189 m
395.8866 552.0189 l
h
f*
256.252 539.0362 m
261.0142 539.0362 l
h
f*
203.4142 500.0315 m
208.1764 500.0315 l
h
f*
212.5984 500.0315 m
217.3606 500.0315 l
h
f*
322.7528 474.0094 m
327.515 474.0094 l
h
f*
427.4079 461.0268 m
432.1701 461.0268 l
h
f*
437.3291 461.0268 m
446.8535 461.0268 l
h
f*
252.5102 396.0567 m
257.2724 396.0567 l
h
f*
262.4315 396.0567 m
271.9559 396.0567 l
h
f*
375.5906 370.0346 m
385.115 370.0346 l
h
f*
390.274 370.0346 m
399.7984 370.0346 l
h
f*
428.5417 344.0126 m
438.0661 344.0126 l
h
f*
443.2819 344.0126 m
452.7496 344.0126 l
h
f*
401.1024 318.0472 m
410.6268 318.0472 l
h
f*
333.7512 305.0646 m
343.2756 305.0646 l
h
f*
236.6929 292.0252 m
246.1606 292.0252 l
h
f*
251.3764 292.0252 m
260.8441 292.0252 l
h
f*
265.3228 292.0252 m
274.8472 292.0252 l
h
f*
282.2173 292.0252 m
291.7417 292.0252 l
h
f*
424.2898 214.0157 m
433.8142 214.0157 l
h
f*
439.0299 214.0157 m
448.4976 214.0157 l
h
f*
504.5669 94.9039 m
514.0913 94.9039 l
h
f*
0 g
1 j
1 J
9.5 0 0 9.5 200.0125 707.7543 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(guidance)Tj
4.225 0 Td
(on)Tj
1.3129 0 Td
(the)Tj
1.5994 0 Td
(pricing)Tj
3.121 0 Td
(of)Tj
1.0444 0 Td
(generic)Tj
3.4553 0 Td
(emtricitabine)Tj
5.6036 0 Td
(/tenofovir)Tj
4.2848 0 Td
(disoproxil)Tj
4.3802 0 Td
(fumarate,)Tj
4.4101 0 Td
(in)Tj
0.9847 0 Td
(order)Tj
2.5243 0 Td
(to)Tj
-36.9457 -1.474 Td
(provide)Tj
3.4552 0 Td
(those)Tj
2.6377 0 Td
(at)Tj
1.0503 0 Td
(high)Tj
2.0768 0 Td
(risk)Tj
1.7604 0 Td
(for)Tj
1.3726 0 Td
(HIV)Tj
1.8798 0 Td
(an)Tj
1.3189 0 Td
(affordable)Tj
4.607 0 Td
(prevention)Tj
4.8338 0 Td
(option)Tj
2.9062 0 Td
(without)Tj
3.3539 0 Td
(financial)Tj
3.8312 0 Td
(burden)Tj
3.2941 0 Td
(on)Tj
-38.3779 -1.474 Td
(individuals)Tj
4.8158 0 Td
(or)Tj
1.0981 0 Td
(jurisdictions)Tj
5.3709 0 Td
(scaling-up)Tj
4.7144 0 Td
(coverage.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 609.1086 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 592.1007 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Men)Tj
2.0862 0 Td
(who)Tj
1.9333 0 Td
(have)Tj
2.0636 0 Td
(sex)Tj
1.4683 0 Td
(with)Tj
1.9956 0 Td
(men)Tj
2.0126 0 Td
(\(MSM\))Tj
3.1634 0 Td
(represent)Tj
3.9571 0 Td
(approximately)Tj
5.9754 0 Td
(4%)Tj
1.4514 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(United)Tj
3.0217 0 Td
(States)Tj
2.5058 0 Td
(\(U.S.\))Tj
-34.1232 -1.2982 Td
(adult)Tj
2.2506 0 Td
(male)Tj
2.143 0 Td
(population,)Tj
4.8189 0 Td
(however,)Tj
3.8381 0 Td
(they)Tj
1.9219 0 Td
(are)Tj
1.4513 0 Td
(disproportionately)Tj
7.6421 0 Td
(affected)Tj
3.3279 0 Td
(by)Tj
1.1792 0 Td
(HIV)Tj
2.0239 0 Td
(due)Tj
1.7008 0 Td
(to)Tj
1.0261 0 Td
(their)Tj
-33.3238 -1.2983 Td
(increased)Tj
3.9968 0 Td
(risk)Tj
1.7178 0 Td
(of)Tj
1.0148 0 Td
(infection)Tj
3.7927 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2586 0 Td
(2)Tj
0 g
(].)Tj
1.2642 0 Td
(In)Tj
1.1055 0 Td
(the)Tj
1.4683 0 Td
(U.S.,)Tj
2.109 0 Td
(MSM)Tj
2.4831 0 Td
(account)Tj
3.3846 0 Td
(for)Tj
1.3833 0 Td
(almost)Tj
2.8856 0 Td
(half)Tj
1.7178 0 Td
(of)Tj
1.0148 0 Td
(people)Tj
2.8517 0 Td
(living)Tj
-33.4486 -1.3039 Td
(with)Tj
1.9955 0 Td
(HIV)Tj
2.024 0 Td
(and)Tj
1.7291 0 Td
(65%)Tj
1.9275 0 Td
(of)Tj
1.0148 0 Td
(all)Tj
1.1452 0 Td
(new)Tj
1.8765 0 Td
(HIV)Tj
2.024 0 Td
(diagnoses)Tj
4.1158 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2586 0 Td
(4)Tj
0 g
(].)Tj
1.2643 0 Td
(The)Tj
1.7801 0 Td
(majority)Tj
3.6283 0 Td
(of)Tj
1.0148 0 Td
(new)Tj
1.8765 0 Td
(diagnoses)Tj
4.1159 0 Td
(are)Tj
1.4457 0 Td
(in)Tj
1.0375 0 Td
(per-)Tj
-35.2741 -1.2983 Td
(sons)Tj
1.9955 0 Td
(of)Tj
1.0148 0 Td
(color)Tj
2.2734 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(].)Tj
-4.0875 -1.2982 Td
(Oral)Tj
2.0182 0 Td
(pre-exposure)Tj
5.4822 0 Td
(prophylaxis)Tj
4.8869 0 Td
(\(PrEP\))Tj
2.9593 0 Td
(can)Tj
1.6271 0 Td
(be)Tj
1.1509 0 Td
(a)Tj
0.6519 0 Td
(highly)Tj
2.7099 0 Td
(effective)Tj
3.5093 0 Td
(HIV)Tj
2.0239 0 Td
(prevention)Tj
4.5808 0 Td
(strategy)Tj
-32.7966 -1.3039 Td
(that)Tj
1.7744 0 Td
(has)Tj
1.5477 0 Td
(the)Tj
1.4684 0 Td
(potential)Tj
3.7587 0 Td
(to)Tj
1.0261 0 Td
(decrease)Tj
3.6057 0 Td
(the)Tj
1.474 0 Td
(number)Tj
3.4129 0 Td
(of)Tj
1.0148 0 Td
(new)Tj
1.8765 0 Td
(HIV)Tj
2.0239 0 Td
(infections)Tj
4.1556 0 Td
(among)Tj
2.9933 0 Td
(MSM)Tj
2.4775 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(U.S)Tj
-35.1153 -1.2983 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2585 0 Td
(6)Tj
0 g
(].)Tj
1.2643 0 Td
(The)Tj
1.7801 0 Td
(original)Tj
3.3279 0 Td
(iPrEX)Tj
2.6362 0 Td
(landmark)Tj
4.0988 0 Td
(study)Tj
2.3925 0 Td
(of)Tj
1.0148 0 Td
(PrEP)Tj
2.279 0 Td
(in)Tj
1.0318 0 Td
(MSM)Tj
2.4831 0 Td
(found)Tj
2.6192 0 Td
(an)Tj
1.2019 0 Td
(overall)Tj
2.9027 0 Td
(44%)Tj
1.9275 0 Td
(reduction)Tj
4.1159 0 Td
(of)Tj
-36.3342 -1.2983 Td
(HIV)Tj
2.0182 0 Td
(transmission.)Tj
5.5899 0 Td
(Effectiveness)Tj
5.3518 0 Td
(was)Tj
1.7007 0 Td
(highly)Tj
2.7099 0 Td
(dependent)Tj
4.4561 0 Td
(on)Tj
1.2756 0 Td
(adherence,)Tj
4.5467 0 Td
(with)Tj
2.0013 0 Td
(a)Tj
0.6519 0 Td
(92%)Tj
1.9276 0 Td
(reduction)Tj
4.1158 0 Td
(in)Tj
-36.3455 -1.3039 Td
(the)Tj
1.4683 0 Td
(high-adherence)Tj
6.4629 0 Td
(subgroup)Tj
4.0025 0 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(].)Tj
1.5988 0 Td
(Subsequent)Tj
4.8245 0 Td
(studies)Tj
2.982 0 Td
(have)Tj
2.0636 0 Td
(found)Tj
2.6192 0 Td
(that)Tj
1.7745 0 Td
(PrEP)Tj
2.2791 0 Td
(reduced)Tj
3.4469 0 Td
(the)Tj
1.4683 0 Td
(inci-)Tj
-34.9906 -1.2983 Td
(dence)Tj
2.5681 0 Td
(of)Tj
1.0148 0 Td
(HIV)Tj
2.0183 0 Td
(infection)Tj
3.7927 0 Td
(by)Tj
1.1792 0 Td
(as)Tj
1.0148 0 Td
(much)Tj
2.5228 0 Td
(as)Tj
1.0148 0 Td
(99%)Tj
1.9276 0 Td
(if)Tj
0.7767 0 Td
(taken)Tj
2.4207 0 Td
(daily)Tj
2.1487 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(].)Tj
3.067 0 Td
(In)Tj
1.1112 0 Td
(2012)Tj
2.1203 0 Td
(the)Tj
1.4684 0 Td
(U.S.)Tj
1.8878 0 Td
(Food)Tj
2.2847 0 Td
(and)Tj
-34.3386 -1.2982 Td
(Drug)Tj
2.3187 0 Td
(Administration)Tj
6.4232 0 Td
(approved)Tj
3.9685 0 Td
(the)Tj
1.4684 0 Td
(use)Tj
1.5363 0 Td
(of)Tj
1.0148 0 Td
(daily)Tj
2.1487 0 Td
(oral)Tj
1.7801 0 Td
(tenofovir)Tj
3.8835 0 Td
(disoproxil)Tj
4.2576 0 Td
(fumarate)Tj
3.8154 0 Td
(and)Tj
1.7291 0 Td
(emtrici-)Tj
-34.3443 -1.2983 Td
(tabine)Tj
2.6985 0 Td
(\(TDF-FTC\))Tj
4.9266 0 Td
(for)Tj
1.389 0 Td
(PrEP,)Tj
2.5001 0 Td
(and)Tj
1.7291 0 Td
(in)Tj
1.0375 0 Td
(2014)Tj
2.126 0 Td
(the)Tj
1.4683 0 Td
(Centers)Tj
3.3109 0 Td
(for)Tj
1.3833 0 Td
(Disease)Tj
3.2258 0 Td
(Control)Tj
3.3618 0 Td
(and)Tj
1.7292 0 Td
(Prevention)Tj
-30.8861 -1.3039 Td
(\(CDC\))Tj
2.9593 0 Td
(published)Tj
4.1272 0 Td
(clinical)Tj
3.0784 0 Td
(guidelines)Tj
4.2746 0 Td
(for)Tj
1.389 0 Td
(its)Tj
1.1452 0 Td
(use)Tj
1.5307 0 Td
(as)Tj
1.0148 0 Td
(PrEP)Tj
2.279 0 Td
(to)Tj
1.0262 0 Td
(prevent)Tj
3.2598 0 Td
(acquisition)Tj
4.6261 0 Td
(of)Tj
1.0148 0 Td
(HIV)Tj
2.0239 0 Td
(infection)Tj
-33.749 -1.2983 Td
(among)Tj
2.9933 0 Td
(high-risk)Tj
3.8551 0 Td
(individuals,)Tj
4.8756 0 Td
(including)Tj
4.0365 0 Td
(MSM,)Tj
2.7099 0 Td
(heterosexual)Tj
5.227 0 Td
(men)Tj
2.0126 0 Td
(and)Tj
1.7291 0 Td
(women,)Tj
3.4299 0 Td
(and)Tj
1.7292 0 Td
(people)Tj
2.8573 0 Td
(who)Tj
-35.4555 -1.2982 Td
(inject)Tj
2.4377 0 Td
(drugs)Tj
2.4718 0 Td
([)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(].)Tj
3.0671 0 Td
(Recent)Tj
2.9593 0 Td
(mathematical)Tj
5.6466 0 Td
(models)Tj
3.1068 0 Td
(have)Tj
2.0579 0 Td
(demonstrated)Tj
5.76 0 Td
(impact)Tj
2.982 0 Td
(and)Tj
1.7291 0 Td
(cost-effec-)Tj
-32.2183 -1.3039 Td
(tiveness)Tj
3.3561 0 Td
(of)Tj
1.0148 0 Td
(PrEP)Tj
2.2791 0 Td
(among)Tj
2.9934 0 Td
(U.S.)Tj
1.8821 0 Td
(MSM)Tj
2.4832 0 Td
(similar)Tj
2.9877 0 Td
(to)Tj
1.0204 0 Td
(findings)Tj
3.498 0 Td
(in)Tj
1.0318 0 Td
(clinical)Tj
3.0784 0 Td
(trials,)Tj
2.4208 0 Td
(but)Tj
1.5533 0 Td
(have)Tj
2.0636 0 Td
(produced)Tj
-31.6627 -1.2983 Td
(mixed)Tj
2.7212 0 Td
(results)Tj
2.8119 0 Td
(in)Tj
1.0318 0 Td
(terms)Tj
2.4945 0 Td
(of)Tj
1.0148 0 Td
(cost-effectiveness)Tj
7.1433 0 Td
([)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(].)Tj
-16.0213 -1.2983 Td
(Despite)Tj
3.2484 0 Td
(overwhelming)Tj
5.9584 0 Td
(evidence)Tj
3.7134 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(effectiveness)Tj
5.2044 0 Td
(of)Tj
1.0148 0 Td
(PrEP)Tj
2.279 0 Td
(at)Tj
0.9525 0 Td
(reducing)Tj
3.7757 0 Td
(the)Tj
1.4683 0 Td
(risk)Tj
1.7178 0 Td
(of)Tj
1.0148 0 Td
(acquir-)Tj
-34.0268 -1.3039 Td
(ing)Tj
1.5023 0 Td
(an)Tj
1.2019 0 Td
(HIV)Tj
2.0182 0 Td
(infection,)Tj
4.0195 0 Td
(its)Tj
1.1452 0 Td
(uptake)Tj
2.9197 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(U.S.)Tj
1.8822 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.1203 0 Td
(low)Tj
1.6555 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(].)Tj
3.5489 0 Td
(Uptake)Tj
3.1238 0 Td
(has)Tj
1.542 0 Td
(increased)Tj
-30.7273 -1.2983 Td
(markedly)Tj
3.9911 0 Td
(over)Tj
1.9786 0 Td
(the)Tj
1.4683 0 Td
(past)Tj
1.8312 0 Td
(few)Tj
1.6157 0 Td
(years)Tj
2.2621 0 Td
(among)Tj
2.999 0 Td
(white)Tj
2.4208 0 Td
(men,)Tj
2.2336 0 Td
(yet)Tj
1.4004 0 Td
(only)Tj
1.9729 0 Td
(a)Tj
0.6519 0 Td
(small)Tj
2.3301 0 Td
(fraction)Tj
3.3562 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(400,000)Tj
-32.995 -1.2982 Td
(men)Tj
2.0125 0 Td
(with)Tj
1.9956 0 Td
(PrEP)Tj
2.2791 0 Td
(indications)Tj
4.6714 0 Td
(were)Tj
2.1203 0 Td
(prescribed)Tj
4.4107 0 Td
(PrEP)Tj
2.279 0 Td
([)Tj
0.83 0.64 0.02 0 k
(20)Tj
0 g
(].)Tj
2.0807 0 Td
(Compared)Tj
4.4843 0 Td
(to)Tj
1.0205 0 Td
(white)Tj
2.4208 0 Td
(men,)Tj
2.2393 0 Td
(uptake)Tj
2.9197 0 Td
(has)Tj
-34.9339 -1.2983 Td
(been)Tj
2.1203 0 Td
(very)Tj
1.9275 0 Td
(low)Tj
1.6554 0 Td
(among)Tj
2.9934 0 Td
(black)Tj
2.3301 0 Td
(men)Tj
2.0069 0 Td
([)Tj
0.83 0.64 0.02 0 k
(21)Tj
0 g
(].)Tj
2.0806 0 Td
(In)Tj
1.1055 0 Td
(large)Tj
2.16 0 Td
(part,)Tj
2.0693 0 Td
(the)Tj
1.4683 0 Td
(low)Tj
1.6554 0 Td
(uptake)Tj
2.9197 0 Td
(can)Tj
1.6271 0 Td
(be)Tj
1.1508 0 Td
(attributed)Tj
4.1726 0 Td
(to)Tj
1.0261 0 Td
(cost)Tj
-34.469 -1.3039 Td
(barriers)Tj
3.3278 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
3.2031 0 Td
(22)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
1.6895 0 Td
(24)Tj
0 g
(].)Tj
1.7348 0 Td
(Out-of-pocket)Tj
5.9527 0 Td
(PrEP)Tj
2.279 0 Td
(costs)Tj
2.1713 0 Td
(approximately)Tj
5.9754 0 Td
($1500)Tj
2.6022 0 Td
(per)Tj
1.5307 0 Td
(month,)Tj
3.1465 0 Td
(although)Tj
-33.613 -1.2983 Td
(manufacturer)Tj
5.6862 0 Td
(and)Tj
1.7291 0 Td
(state)Tj
2.0353 0 Td
(and)Tj
1.7291 0 Td
(city)Tj
1.6668 0 Td
(medication)Tj
4.7338 0 Td
(assistance)Tj
4.1329 0 Td
(programs)Tj
4.0649 0 Td
(might)Tj
2.6021 0 Td
(pay)Tj
1.6271 0 Td
(prescription)Tj
5.091 0 Td
(costs)Tj
-35.0983 -1.2982 Td
(for)Tj
1.3832 0 Td
(those)Tj
2.3415 0 Td
(who)Tj
1.9388 0 Td
(qualify.)Tj
3.1692 0 Td
(The)Tj
1.7801 0 Td
(majority)Tj
3.6283 0 Td
(of)Tj
1.0148 0 Td
(private)Tj
2.9877 0 Td
(insurance)Tj
4.1272 0 Td
(companies)Tj
4.5184 0 Td
(cover)Tj
2.3981 0 Td
(PrEP,)Tj
2.5058 0 Td
(but)Tj
1.5534 0 Td
(high)Tj
-33.3465 -1.304 Td
(insurance)Tj
4.1215 0 Td
(premiums,)Tj
4.5524 0 Td
(deductibles,)Tj
4.9833 0 Td
(and)Tj
1.7291 0 Td
(co-payments)Tj
5.3575 0 Td
(can)Tj
1.627 0 Td
(make)Tj
2.3925 0 Td
(PrEP)Tj
2.279 0 Td
(unaffordable)Tj
5.3234 0 Td
(for)Tj
1.3833 0 Td
(low-)Tj
-33.749 -1.2982 Td
(income,)Tj
3.4355 0 Td
(high-risk)Tj
3.8494 0 Td
(individuals.)Tj
4.8756 0 Td
(As)Tj
1.2642 0 Td
(jurisdictions)Tj
5.2044 0 Td
(and)Tj
1.7348 0 Td
(health)Tj
2.6759 0 Td
(organizations)Tj
5.6409 0 Td
(make)Tj
2.3924 0 Td
(important)Tj
4.2803 0 Td
(deci-)Tj
-35.3534 -1.2983 Td
(sions)Tj
2.262 0 Td
(about)Tj
2.4945 0 Td
(supporting)Tj
4.6034 0 Td
(PrEP)Tj
2.279 0 Td
(scale-up,)Tj
3.7247 0 Td
(the)Tj
1.474 0 Td
(clinical)Tj
3.0728 0 Td
(and)Tj
1.7291 0 Td
(economic)Tj
4.1442 0 Td
(impact)Tj
2.9764 0 Td
(that)Tj
1.7801 0 Td
(results)Tj
2.8063 0 Td
(from)Tj
2.2054 0 Td
(high)Tj
-35.5519 -1.3039 Td
(drug)Tj
2.1089 0 Td
(pricing)Tj
3.0841 0 Td
(needs)Tj
2.5001 0 Td
(to)Tj
1.0262 0 Td
(be)Tj
1.1508 0 Td
(understood.)Tj
5.0457 0 Td
(Previous)Tj
3.6906 0 Td
(analyses)Tj
3.481 0 Td
([)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(])Tj
3.3222 0 Td
(have)Tj
2.0579 0 Td
(evaluated)Tj
3.9911 0 Td
(PrEP)Tj
2.2791 0 Td
(cost-)Tj
-33.7377 -1.2983 Td
(effectiveness)Tj
5.2043 0 Td
(at)Tj
0.9525 0 Td
(the)Tj
1.4683 0 Td
(current)Tj
3.1861 0 Td
(drug)Tj
2.109 0 Td
(price,)Tj
2.4491 0 Td
(generally)Tj
3.8324 0 Td
(concluding)Tj
4.7055 0 Td
(that)Tj
1.7801 0 Td
(PrEP)Tj
2.2791 0 Td
(is)Tj
0.8447 0 Td
(cost-effective)Tj
5.4538 0 Td
(in)Tj
1.0318 0 Td
(high)Tj
-35.2967 -1.2982 Td
(risk)Tj
1.7121 0 Td
(populations)Tj
4.9549 0 Td
(\(e.g.)Tj
1.8992 0 Td
(high)Tj
2.0069 0 Td
(background)Tj
5.0286 0 Td
(HIV)Tj
2.024 0 Td
(prevalence\).)Tj
5.0513 0 Td
(In)Tj
1.1055 0 Td
(the)Tj
1.4683 0 Td
(analysis)Tj
3.3279 0 Td
(we)Tj
1.3266 0 Td
(describe)Tj
3.5263 0 Td
(in)Tj
1.0374 0 Td
(this)Tj
-34.469 -1.3039 Td
(article,)Tj
2.9083 0 Td
(we)Tj
1.3266 0 Td
(consider)Tj
3.651 0 Td
(cost-effectiveness)Tj
7.1432 0 Td
(under)Tj
2.6192 0 Td
(alternative)Tj
4.4221 0 Td
(pricing)Tj
3.0784 0 Td
(for)Tj
1.3833 0 Td
(PrEP,)Tj
2.5058 0 Td
(in)Tj
1.0375 0 Td
(order)Tj
2.4207 0 Td
(to)Tj
1.0262 0 Td
(help)Tj
1.9332 0 Td
(iden-)Tj
-35.4555 -1.2983 Td
(tify)Tj
1.525 0 Td
(a)Tj
0.6576 0 Td
(price)Tj
2.2224 0 Td
(point)Tj
2.3584 0 Td
(at)Tj
0.9524 0 Td
(which)Tj
2.6475 0 Td
(large-scale)Tj
4.3994 0 Td
(delivery)Tj
3.3902 0 Td
(of)Tj
1.0148 0 Td
(PrEP)Tj
2.279 0 Td
(to)Tj
1.0262 0 Td
(MSM)Tj
2.4774 0 Td
(is)Tj
0.8504 0 Td
(economically)Tj
5.5219 0 Td
(justified.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 131.0173 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Methods)Tj
/F0 1 Tf
0 -1.5023 Td
(Model)Tj
2.9102 0 Td
(structure)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 95.9811 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(We)Tj
1.61 0 Td
(modified)Tj
3.8438 0 Td
(a)Tj
0.6576 0 Td
(previously)Tj
4.3483 0 Td
(published)Tj
4.1272 0 Td
(and)Tj
1.7292 0 Td
(described)Tj
4.0535 0 Td
(decision-analysis)Tj
7.0015 0 Td
(model)Tj
2.7439 0 Td
([)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(])Tj
1.8482 0 Td
(to)Tj
1.0261 0 Td
(estimate)Tj
-32.9893 -1.2982 Td
(the)Tj
1.4683 0 Td
(cost)Tj
1.8085 0 Td
(effectiveness)Tj
5.2044 0 Td
(ratio)Tj
2.0976 0 Td
(\(CER\),)Tj
2.982 0 Td
(or)Tj
1.0942 0 Td
(the)Tj
1.474 0 Td
(cost)Tj
1.8085 0 Td
(per)Tj
1.5307 0 Td
(quality-adjusted)Tj
6.6613 0 Td
(life)Tj
1.4457 0 Td
(year)Tj
1.9049 0 Td
(\(QALY\))Tj
3.4979 0 Td
(gained,)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 306.085 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Optimal)Tj
3.6071 0 Td
(costs)Tj
2.5228 0 Td
(of)Tj
1.0418 0 Td
(HIV)Tj
1.8638 0 Td
(pre-exposure)Tj
6.0095 0 Td
(prophylax)Tj
4.252 0 Td
(is)Tj
0.9283 0 Td
(for)Tj
1.3677 0 Td
(men)Tj
2.1331 0 Td
(who)Tj
2.0268 0 Td
(have)Tj
2.3457 0 Td
(sex)Tj
1.7575 0 Td
(with)Tj
1.963 0 Td
(men)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01781)Tj
4.089 0 Td
(70)Tj
0 g
2.0906 0 Td
(June)Tj
2.3528 0 Td
(1,)Tj
1.0417 0 Td
(2017)Tj
35.5113 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
endstream
endobj
52 0 obj
<>stream
endstream
endobj
53 0 obj
<>stream
endstream
endobj
54 0 obj
<>stream
endstream
endobj
55 0 obj
<>stream
endstream
endobj
56 0 obj
<>stream
endstream
endobj
57 0 obj
<>stream
endstream
endobj
58 0 obj
<>stream
endstream
endobj
59 0 obj
<>stream
endstream
endobj
60 0 obj
<>stream
endstream
endobj
61 0 obj
<>stream
BT
66.402 0 Td
(13)Tj
ET
Q
endstream
endobj
62 0 obj
<>/ColorSpace<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 9 0 R/Annots 66 0 R/Contents 67 0 R/TrimBox[0 0 612 792]>>
endobj
65 0 obj
[/ICCBased 68 0 R]
endobj
68 0 obj
<>stream
xwTSϽ7PkhRH
H.*1 J "6DTpDQ2(C"QDqpIdy͛~kg}ֺ LX Xňg` l pBF|،l *? Y"1 P\8=W%Oɘ4M0J"Y2Vs,[|e92<se'9`2&ctI@o|N6 (.sSdl-c(2-y H_/XZ.$&\SM07#1ؙYr fYym";8980m-m(]v^DW~
emi ]P`/ u}q|^R,g+\Kk)/C_|Rax8t1C^7nfzDp柇u$/ED˦L L[B@ٹЖX!@~ (* {d+}G͋љς}WL$cGD2QZ4 E@@ A(q`1D `'u46ptc48.`R0)
@Rt CXCP%CBH@Rf[(t
CQhz#0 Zl`O828.p|O×X
?:0FBx$ !i@ڐH[EE1PL⢖V6QP>U(j
MFk t,:.FW8c1L&ӎ9ƌaX:
rbl1
{{{;}#tp8_\8"Ey.,X%%Gщ1-9ҀKl.oo/O$&'=JvMޞ